To the Editor:
We published a strategy for screening of latent tuberculosis infection (LTBI) for prevention of TB flare among patients with inflammatory rheumatic diseases (IRD) receiving tumor necrosis factor-α (TNF-α) inhibitors1. Flare of LTBI has been a serious problem among patients receiving monoclonal antibody-based TNF-α inhibitors in high-burden TB regions of the world, including India. We present results on an additional 33 patients …
Address correspondence to Dr. A.N. Malaviya, Flat 2015, Sector B-2, Vasant Kunj, New Delhi, 110070, India; E-mail: anand_malaviya{at}yahoo.com